Goldline Pharmaceutical IPO GMP
Listed
Historical GMP record
Grey market premium history vs actual listing price
Goldline Pharmaceutical IPO's final recorded GMP before listing was ₹14 per share (a 33% premium over the ₹43 upper price band). The shares listed at ₹59.75. GMP is unofficial and does not forecast or guarantee the actual listing price.
Goldline Pharmaceutical IPO GMP vs actual listing price
The indicative price was a grey-market calculation, not a forecast. The actual listing price is determined on the exchange and can differ materially from GMP-based figures.
Goldline Pharmaceutical IPO GMP history (day-wise)
Last recorded grey-market quote for each day, newest first. Across the recorded period, Goldline Pharmaceutical IPO GMP ranged from ₹4 to ₹17.
| Date | GMP (₹) | Change | GMP % | Indicative Listing (₹) = upper price band + GMP. Indicative only, not a forecast. |
|---|---|---|---|---|
| +₹14 | ₹0 | +33% | ₹57 | |
| +₹14 | +₹2 | +33% | ₹57 | |
| +₹12 | +₹4 | +28% | ₹55 | |
| +₹8 | +₹2 | +19% | ₹51 | |
| +₹6 | +₹2 | +14% | ₹49 | |
| +₹4 | — | +9% | ₹47 |
Goldline Pharmaceutical IPO details
| Price Band | ₹41-43 |
|---|---|
| Lot Size | 3000 shares |
| Issue Size | 27,00,000 shares(agg. up to ₹11.61 Cr) |
| Listing At | BSE SME |
| Open Date | May 12, 2026 |
| Close Date | May 14, 2026 |
| Allotment Date | May 15, 2026 |
| Listing Date | May 19, 2026 |
How IPO Ji updates GMP data
- Source: GMP figures come from IPO Ji's informal-market data feed and are not exchange-published prices.
- Calculation: GMP % = GMP ÷ upper price band × 100. Indicative listing price = upper price band + GMP.
- Freshness: Timestamps are shown in IST and the page reflects the most recently recorded quote. A value without a reliable timestamp is not labelled “today” or “current”.
- Editorial policy: IPO Ji reports the recorded figure without ranking IPOs or recommending an application decision.
GMP can change without notice and may differ materially from the actual listing price.
FAQs
Goldline Pharmaceutical IPO GMP — Frequently Asked Questions
What was Goldline Pharmaceutical IPO GMP before listing?
Goldline Pharmaceutical IPO's final recorded GMP before listing was ₹14 per share (a 33% premium over the ₹43 upper price band). The shares listed at ₹59.75. GMP is unofficial and does not forecast or guarantee the actual listing price.
What is the indicative listing price of Goldline Pharmaceutical IPO?
The indicative listing price of Goldline Pharmaceutical IPO was ₹57, calculated as the ₹43 upper price band + ₹14 GMP. This figure is based on unofficial grey-market quotes; it is indicative only and not a forecast or guarantee of the actual listing price.
Is Goldline Pharmaceutical IPO GMP a guarantee of the listing price?
No. GMP is unofficial, unregulated grey-market information and does not forecast or guarantee the actual listing price of Goldline Pharmaceutical IPO. It can change quickly and may differ materially from the eventual exchange price. IPO Ji reports it for information only and does not deal in or facilitate grey-market transactions.
When will Goldline Pharmaceutical IPO list?
Goldline Pharmaceutical IPO has listed on May 19, 2026 on BSE SME. The shares listed at ₹59.75.
How often is Goldline Pharmaceutical IPO GMP updated?
The Goldline Pharmaceutical IPO GMP on this page refreshes whenever a new grey-market figure is recorded in IPO Ji's data feed; the latest recorded quote is from 17 May 2026, 10:00 AM IST. Because the grey market is informal, figures are indicative and can change through the day.